Brief: Klaria Pharma And Karessa Pharma To Merge

Klaria Pharma Holding AB (publ)

05/11/2019 08:06

Nov 5 (Reuters) - Karessa Pharma Holding Ab (Publ)
 KARE.ST :
    * KLARIA PHARMA HOLDING AND KARESSA PHARMA HOLDING MERGE TO
CREATE
A FOCUSED DRUG DEVELOPMENT COMPANY WITH A STRONG PIPELINE AND A
WHOLLY-OWNED DRUG-DELIVERY TECHNOLOGY PLATFORM
    * KLARIA'S AND KARESSA'S BOARD OF DIRECTORS ADOPTED, A JOINT
MERGER PLAN ACCORDING TO WHICH KLARIA AND KARESSA HAVE AGREED ON
MERGER
    * UPON COMPLETION OF MERGER, BJÖRN LITTORIN, ANDERS ARDSTÅL
AND
SCOTT BOYER ARE EXPECTED TO BE BOARD MEMBERS OF NEW KLARIA
PHARMA, AND SCOTT BOYER TO BE NEW KLARIA PHARMA'S CEO
    * MERGER REQUIRES, AMONG OTHER THINGS, APPROVALS AT
EXTRAORDINARY
GENERAL MEETINGS OF TWO COMPANIES

Source text for Eikon:  ID:nWkr1FZy09 
Further company coverage:  KARE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))